Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou4f1
|
ENSMUSG00000048349.8 | POU domain, class 4, transcription factor 1 |
Pou6f1
|
ENSMUSG00000009739.10 | POU domain, class 6, transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_104468407_104468595 | Pou4f1 | 502 | 0.779932 | 0.82 | 3.1e-14 | Click! |
chr14_104473286_104473439 | Pou4f1 | 5363 | 0.187388 | 0.74 | 1.1e-10 | Click! |
chr14_104468197_104468390 | Pou4f1 | 294 | 0.896075 | 0.64 | 1.3e-07 | Click! |
chr14_104467561_104468151 | Pou4f1 | 143 | 0.955689 | 0.63 | 2.4e-07 | Click! |
chr14_104467312_104467463 | Pou4f1 | 612 | 0.715646 | 0.60 | 1.4e-06 | Click! |
chr15_100599610_100600576 | Pou6f1 | 109 | 0.483750 | 0.55 | 1.1e-05 | Click! |
chr15_100599382_100599598 | Pou6f1 | 374 | 0.589448 | 0.41 | 2.1e-03 | Click! |
chr15_100598891_100599144 | Pou6f1 | 847 | 0.324689 | 0.38 | 4.6e-03 | Click! |
chr15_100574768_100574919 | Pou6f1 | 5388 | 0.105412 | -0.22 | 1.0e-01 | Click! |
chr15_100574041_100574216 | Pou6f1 | 6103 | 0.102732 | -0.10 | 4.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_77236959_77237505 | 67.49 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
913 |
0.66 |
chr7_16134906_16135134 | 64.76 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
4672 |
0.13 |
chr13_85066695_85066901 | 52.32 |
Gm47745 |
predicted gene, 47745 |
27537 |
0.17 |
chrX_22850177_22850580 | 43.81 |
Gm26131 |
predicted gene, 26131 |
11558 |
0.32 |
chr7_51748719_51749329 | 42.93 |
Gm7336 |
predicted gene 7336 |
2377 |
0.28 |
chr10_112876780_112876938 | 41.86 |
Gm3942 |
predicted gene 3942 |
39107 |
0.13 |
chr7_76185386_76185573 | 41.11 |
Agbl1 |
ATP/GTP binding protein-like 1 |
44408 |
0.17 |
chr14_38825108_38825292 | 40.86 |
Nrg3os |
neuregulin 3, opposite strand |
73102 |
0.12 |
chr16_66969715_66969926 | 40.72 |
Cadm2 |
cell adhesion molecule 2 |
16486 |
0.28 |
chr7_132767494_132767645 | 40.44 |
Fam53b |
family with sequence similarity 53, member B |
9347 |
0.2 |
chr5_32278343_32278541 | 40.35 |
Plb1 |
phospholipase B1 |
31091 |
0.13 |
chr5_27873156_27873523 | 40.04 |
Gm5551 |
predicted gene 5551 |
12890 |
0.15 |
chr13_44100199_44100380 | 38.91 |
Gm33630 |
predicted gene, 33630 |
329 |
0.89 |
chr15_92161110_92161283 | 38.50 |
Cntn1 |
contactin 1 |
161 |
0.97 |
chr6_101422696_101422871 | 37.39 |
Pdzrn3 |
PDZ domain containing RING finger 3 |
44886 |
0.13 |
chr7_51339973_51340169 | 36.75 |
Gm45002 |
predicted gene 45002 |
54758 |
0.15 |
chr12_49945819_49946221 | 36.37 |
Gm7481 |
predicted gene 7481 |
104269 |
0.08 |
chr13_84566286_84566489 | 35.77 |
Gm26913 |
predicted gene, 26913 |
124554 |
0.06 |
chr2_153425549_153426538 | 35.76 |
Gm14472 |
predicted gene 14472 |
12194 |
0.16 |
chr1_115784817_115785014 | 35.65 |
Cntnap5a |
contactin associated protein-like 5A |
100159 |
0.08 |
chr15_30457525_30457710 | 35.47 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
56 |
0.98 |
chr18_25678184_25678915 | 35.03 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chr15_85461506_85461895 | 34.76 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
41527 |
0.13 |
chr12_51002047_51002408 | 34.64 |
Gm40421 |
predicted gene, 40421 |
2646 |
0.28 |
chr8_70118830_70119054 | 34.61 |
Ncan |
neurocan |
1931 |
0.15 |
chr13_84905713_84906063 | 34.35 |
Gm4059 |
predicted gene 4059 |
68429 |
0.12 |
chr13_29015223_29015589 | 34.27 |
A330102I10Rik |
RIKEN cDNA A330102I10 gene |
887 |
0.68 |
chrX_93310672_93310849 | 34.21 |
Arx |
aristaless related homeobox |
24250 |
0.21 |
chr7_16135179_16135505 | 34.11 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
4994 |
0.13 |
chr8_53600519_53600706 | 34.06 |
Neil3 |
nei like 3 (E. coli) |
9007 |
0.27 |
chr2_141074295_141074486 | 33.88 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
50328 |
0.15 |
chr12_65216661_65216843 | 33.78 |
Gm31063 |
predicted gene, 31063 |
3251 |
0.19 |
chr6_22984216_22984575 | 33.50 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
1914 |
0.44 |
chr9_73681080_73681313 | 33.46 |
Gm27148 |
predicted gene 27148 |
4504 |
0.32 |
chr9_37001994_37002204 | 33.23 |
Gm3896 |
predicted gene 3896 |
13659 |
0.15 |
chr12_105898639_105899296 | 33.12 |
Gm19554 |
predicted gene, 19554 |
874 |
0.59 |
chr13_28420360_28420511 | 33.12 |
Gm40841 |
predicted gene, 40841 |
369 |
0.9 |
chr4_12629424_12629825 | 32.95 |
Gm37985 |
predicted gene, 37985 |
32236 |
0.24 |
chr12_108395688_108396506 | 32.77 |
Eml1 |
echinoderm microtubule associated protein like 1 |
14445 |
0.17 |
chr11_37936852_37937003 | 32.70 |
Gm25693 |
predicted gene, 25693 |
100336 |
0.09 |
chr15_25761802_25762209 | 32.42 |
Myo10 |
myosin X |
3220 |
0.3 |
chr11_44900591_44900793 | 32.38 |
Ebf1 |
early B cell factor 1 |
11446 |
0.29 |
chr5_77838512_77838806 | 32.32 |
Gm42673 |
predicted gene 42673 |
70801 |
0.12 |
chr1_162410707_162410867 | 32.27 |
Dnm3 |
dynamin 3 |
3452 |
0.29 |
chr15_40533683_40533834 | 31.87 |
Gm7382 |
predicted gene 7382 |
3563 |
0.28 |
chr8_124386596_124386768 | 31.81 |
Pgbd5 |
piggyBac transposable element derived 5 |
6534 |
0.19 |
chr19_23388976_23389167 | 31.75 |
Gm50445 |
predicted gene, 50445 |
29272 |
0.16 |
chr13_78937424_78937962 | 31.63 |
Gm8345 |
predicted gene 8345 |
17099 |
0.29 |
chr5_112825174_112825344 | 31.37 |
1700095B10Rik |
RIKEN cDNA 1700095B10 gene |
31927 |
0.16 |
chr3_119154673_119154893 | 31.30 |
Gm43410 |
predicted gene 43410 |
286539 |
0.01 |
chr16_35592451_35593042 | 31.11 |
Gm5963 |
predicted pseudogene 5963 |
19190 |
0.18 |
chr3_80334654_80334917 | 31.00 |
Gm37971 |
predicted gene, 37971 |
190 |
0.96 |
chr1_35957784_35957967 | 30.95 |
Gm8022 |
predicted gene 8022 |
1044 |
0.49 |
chr2_63963076_63963322 | 30.57 |
Fign |
fidgetin |
134789 |
0.06 |
chr10_26827294_26827613 | 30.51 |
Arhgap18 |
Rho GTPase activating protein 18 |
4851 |
0.26 |
chr16_58136583_58136869 | 30.11 |
Gm49574 |
predicted gene, 49574 |
101378 |
0.07 |
chr13_58964694_58965094 | 29.90 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
93159 |
0.06 |
chr17_57799511_57799698 | 29.89 |
Cntnap5c |
contactin associated protein-like 5C |
30034 |
0.13 |
chr4_71230174_71230407 | 29.60 |
Gm11229 |
predicted gene 11229 |
55652 |
0.15 |
chr14_93067075_93067302 | 29.57 |
Gm23509 |
predicted gene, 23509 |
71001 |
0.12 |
chr12_58512843_58513053 | 29.39 |
Clec14a |
C-type lectin domain family 14, member a |
243658 |
0.02 |
chr5_91909293_91909484 | 29.26 |
Gm43688 |
predicted gene 43688 |
4015 |
0.19 |
chr12_29526481_29526772 | 29.16 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.41 |
chr1_119388694_119389073 | 28.72 |
Inhbb |
inhibin beta-B |
33365 |
0.14 |
chr12_5215893_5216095 | 28.70 |
Gm48532 |
predicted gene, 48532 |
19970 |
0.23 |
chr9_61509897_61510259 | 28.66 |
Gm34424 |
predicted gene, 34424 |
355 |
0.89 |
chr9_61573670_61573999 | 28.64 |
Gm34424 |
predicted gene, 34424 |
40419 |
0.18 |
chr13_113917716_113918082 | 28.45 |
Arl15 |
ADP-ribosylation factor-like 15 |
123277 |
0.05 |
chr4_85763241_85763411 | 28.24 |
Adamtsl1 |
ADAMTS-like 1 |
248999 |
0.02 |
chr1_124652334_124652530 | 27.75 |
Gm28299 |
predicted gene 28299 |
36836 |
0.22 |
chr1_13936038_13936249 | 27.73 |
Gm36947 |
predicted gene, 36947 |
87024 |
0.09 |
chr5_113041463_113042083 | 27.56 |
Gm22740 |
predicted gene, 22740 |
2371 |
0.2 |
chr12_45598321_45598472 | 27.45 |
Gm48517 |
predicted gene, 48517 |
25109 |
0.23 |
chr13_83739197_83739995 | 27.43 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
733 |
0.33 |
chr9_78880685_78880932 | 27.02 |
Gm47498 |
predicted gene, 47498 |
55975 |
0.11 |
chr12_27082382_27083027 | 27.00 |
Gm9866 |
predicted gene 9866 |
32291 |
0.24 |
chr13_109926664_109927017 | 26.99 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
4 |
0.99 |
chr8_49461917_49462068 | 26.87 |
4930555F03Rik |
RIKEN cDNA 4930555F03 gene |
1331 |
0.41 |
chr6_33739125_33739298 | 26.73 |
Exoc4 |
exocyst complex component 4 |
37777 |
0.19 |
chr8_40633457_40633627 | 26.73 |
Mtmr7 |
myotubularin related protein 7 |
1217 |
0.44 |
chr5_100108777_100109262 | 26.70 |
Tmem150c |
transmembrane protein 150C |
13777 |
0.15 |
chr4_12334563_12334783 | 26.57 |
Gm11846 |
predicted gene 11846 |
63274 |
0.12 |
chr5_131645657_131645846 | 26.37 |
Gm43483 |
predicted gene 43483 |
2944 |
0.17 |
chr7_72774438_72774794 | 26.34 |
Gm7693 |
predicted gene 7693 |
60995 |
0.12 |
chr13_48013586_48013800 | 26.27 |
4931429P17Rik |
RIKEN cDNA 4931429P17 gene |
4915 |
0.25 |
chr5_131775416_131775620 | 26.21 |
Gm42442 |
predicted gene 42442 |
77165 |
0.07 |
chr9_75085301_75085493 | 26.13 |
Gm9719 |
predicted gene 9719 |
13743 |
0.14 |
chr16_77851796_77851975 | 26.06 |
Gm17333 |
predicted gene, 17333 |
5281 |
0.28 |
chr13_26656976_26657325 | 25.96 |
Gm47883 |
predicted gene, 47883 |
23543 |
0.23 |
chr5_97415807_97416224 | 25.72 |
4930467D21Rik |
RIKEN cDNA 4930467D21 gene |
23568 |
0.17 |
chr15_18818116_18818289 | 25.65 |
C030047K22Rik |
RIKEN cDNA C030047K22 gene |
572 |
0.56 |
chr2_123364225_123364551 | 25.55 |
Gm13988 |
predicted gene 13988 |
90464 |
0.1 |
chr7_76392345_76392603 | 25.48 |
Agbl1 |
ATP/GTP binding protein-like 1 |
18588 |
0.28 |
chr9_43699339_43700154 | 25.41 |
Gm5364 |
predicted gene 5364 |
16693 |
0.14 |
chr7_93336531_93336711 | 25.26 |
Gm44947 |
predicted gene 44947 |
12671 |
0.22 |
chr2_148650604_148650755 | 25.21 |
Nxt1 |
NTF2-related export protein 1 |
21922 |
0.14 |
chr3_34659334_34659485 | 25.09 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
3373 |
0.14 |
chr4_39345030_39345334 | 25.05 |
Gm23607 |
predicted gene, 23607 |
49719 |
0.14 |
chr9_45676646_45676829 | 25.02 |
Dscaml1 |
DS cell adhesion molecule like 1 |
3900 |
0.23 |
chr13_82130194_82130345 | 25.00 |
Gm48155 |
predicted gene, 48155 |
40512 |
0.19 |
chr18_25525761_25525937 | 24.94 |
Celf4 |
CUGBP, Elav-like family member 4 |
24610 |
0.23 |
chr1_147187366_147187538 | 24.94 |
Gm9931 |
predicted gene 9931 |
94490 |
0.09 |
chr6_50777784_50778006 | 24.90 |
C530044C16Rik |
RIKEN cDNA C530044C16 gene |
1571 |
0.34 |
chr6_53593787_53593938 | 24.84 |
Creb5 |
cAMP responsive element binding protein 5 |
20486 |
0.24 |
chr5_70842284_70842796 | 24.83 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
77 |
0.99 |
chr7_46422213_46422380 | 24.82 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
384 |
0.84 |
chr1_69157499_69157702 | 24.62 |
Gm8840 |
predicted gene 8840 |
26301 |
0.2 |
chr10_23016379_23016546 | 24.57 |
Gm47787 |
predicted gene, 47787 |
59878 |
0.13 |
chr1_97863217_97863535 | 24.50 |
Pam |
peptidylglycine alpha-amidating monooxygenase |
1088 |
0.54 |
chr3_144545820_144546021 | 24.45 |
Gm43560 |
predicted gene 43560 |
21919 |
0.13 |
chr8_109252441_109252632 | 24.44 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
2670 |
0.38 |
chr16_63747767_63748162 | 24.43 |
Gm22769 |
predicted gene, 22769 |
430 |
0.91 |
chr14_15785133_15785550 | 24.39 |
Gm31804 |
predicted gene, 31804 |
11652 |
0.26 |
chr14_99944188_99944685 | 24.38 |
Klf12 |
Kruppel-like factor 12 |
728 |
0.78 |
chr14_64595318_64595919 | 24.37 |
Mir3078 |
microRNA 3078 |
4433 |
0.18 |
chr7_120504381_120504651 | 24.35 |
Gm9165 |
predicted gene 9165 |
142 |
0.95 |
chr7_73354299_73354479 | 23.83 |
Rgma |
repulsive guidance molecule family member A |
21120 |
0.13 |
chr2_92920841_92921005 | 23.61 |
Syt13 |
synaptotagmin XIII |
5825 |
0.2 |
chr13_24629399_24629595 | 23.60 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
9151 |
0.2 |
chr17_85874235_85874607 | 23.44 |
Gm29418 |
predicted gene 29418 |
50377 |
0.14 |
chr4_107681159_107681323 | 23.41 |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
281 |
0.86 |
chr3_88206531_88206915 | 23.30 |
Gm3764 |
predicted gene 3764 |
90 |
0.91 |
chr15_66238948_66239591 | 23.26 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46782 |
0.14 |
chr2_53437450_53438022 | 23.07 |
Gm13501 |
predicted gene 13501 |
39249 |
0.2 |
chr14_75235954_75236330 | 23.06 |
Cpb2 |
carboxypeptidase B2 (plasma) |
6145 |
0.15 |
chr18_38379687_38380169 | 23.00 |
Gm4949 |
predicted gene 4949 |
19390 |
0.11 |
chr3_40673832_40673983 | 22.97 |
Intu |
inturned planar cell polarity protein |
1286 |
0.42 |
chr5_110406260_110406691 | 22.91 |
Fbrsl1 |
fibrosin-like 1 |
19379 |
0.12 |
chr3_7041540_7041692 | 22.85 |
Gm22074 |
predicted gene, 22074 |
64348 |
0.14 |
chr2_162282115_162282295 | 22.81 |
Ptprtos |
protein tyrosine phosphatase, receptor type T, opposite strand |
108608 |
0.07 |
chr1_66323589_66323774 | 22.80 |
Map2 |
microtubule-associated protein 2 |
1579 |
0.37 |
chr18_88040235_88040423 | 22.79 |
Gm50391 |
predicted gene, 50391 |
56221 |
0.16 |
chr2_51088193_51088355 | 22.77 |
Rnd3 |
Rho family GTPase 3 |
60820 |
0.14 |
chr15_41082277_41082449 | 22.75 |
Gm49524 |
predicted gene, 49524 |
84403 |
0.09 |
chr3_107114477_107114841 | 22.74 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
11977 |
0.14 |
chr8_48458356_48458774 | 22.69 |
Tenm3 |
teneurin transmembrane protein 3 |
96748 |
0.08 |
chr12_41727156_41727860 | 22.66 |
Gm47369 |
predicted gene, 47369 |
43114 |
0.18 |
chr12_117054555_117054730 | 22.63 |
Gm10421 |
predicted gene 10421 |
96573 |
0.08 |
chr16_26528369_26528590 | 22.38 |
Tmem207 |
transmembrane protein 207 |
1710 |
0.45 |
chr8_35608109_35608279 | 22.38 |
Mfhas1 |
malignant fibrous histiocytoma amplified sequence 1 |
917 |
0.59 |
chr3_5755164_5755385 | 22.22 |
Gm8797 |
predicted pseudogene 8797 |
4468 |
0.32 |
chr12_44403738_44404185 | 22.20 |
Gm48182 |
predicted gene, 48182 |
5829 |
0.21 |
chr11_34297799_34297993 | 22.19 |
4930403D09Rik |
RIKEN cDNA 4930403D09 gene |
1811 |
0.35 |
chr2_13177815_13177978 | 22.15 |
Gm37780 |
predicted gene, 37780 |
14273 |
0.2 |
chr6_103810795_103811013 | 22.14 |
Gm25656 |
predicted gene, 25656 |
21674 |
0.25 |
chr19_52647066_52647670 | 22.12 |
AA387883 |
expressed sequence AA387883 |
275813 |
0.01 |
chr2_48538627_48539050 | 22.08 |
Gm13481 |
predicted gene 13481 |
81593 |
0.1 |
chr1_89541260_89541455 | 22.00 |
Gm25180 |
predicted gene, 25180 |
22003 |
0.16 |
chr18_23494681_23494880 | 21.94 |
Dtna |
dystrobrevin alpha |
2055 |
0.46 |
chr1_5232314_5232482 | 21.93 |
Gm7182 |
predicted gene 7182 |
44939 |
0.16 |
chr13_84805083_84805258 | 21.92 |
Gm26913 |
predicted gene, 26913 |
114229 |
0.06 |
chr6_52119364_52119515 | 21.89 |
Rps8-ps3 |
ribosomal protein S8, pseudogene 3 |
1197 |
0.26 |
chr7_137906593_137906744 | 21.89 |
Gm5650 |
predicted gene 5650 |
155338 |
0.04 |
chr12_90132535_90132958 | 21.88 |
Gm48700 |
predicted gene, 48700 |
64647 |
0.14 |
chr17_69769280_69769433 | 21.87 |
Gm49895 |
predicted gene, 49895 |
6656 |
0.3 |
chr17_50908659_50908814 | 21.86 |
Gm25177 |
predicted gene, 25177 |
8305 |
0.29 |
chr10_38357630_38357792 | 21.86 |
Gm48197 |
predicted gene, 48197 |
43865 |
0.17 |
chr19_38348438_38348761 | 21.84 |
Gm50150 |
predicted gene, 50150 |
5985 |
0.16 |
chr2_96401290_96401481 | 21.80 |
Lrrc4c |
leucine rich repeat containing 4C |
83169 |
0.11 |
chr12_86814732_86815100 | 21.79 |
Gm10095 |
predicted gene 10095 |
31551 |
0.15 |
chr13_84783122_84783632 | 21.77 |
Gm26913 |
predicted gene, 26913 |
92436 |
0.09 |
chr13_54282796_54282992 | 21.71 |
Gm48623 |
predicted gene, 48623 |
19065 |
0.15 |
chr12_106129460_106129620 | 21.71 |
Gm47646 |
predicted gene, 47646 |
15860 |
0.18 |
chr8_9929838_9929989 | 21.70 |
Gm10067 |
predicted gene 10067 |
10450 |
0.17 |
chr14_14949137_14949288 | 21.61 |
Nek10 |
NIMA (never in mitosis gene a)- related kinase 10 |
18637 |
0.22 |
chr9_58065580_58065817 | 21.59 |
Stra6 |
stimulated by retinoic acid gene 6 |
1910 |
0.25 |
chr19_33391464_33392505 | 21.59 |
Rnls |
renalase, FAD-dependent amine oxidase |
281 |
0.91 |
chr10_95619676_95619912 | 21.58 |
Gm33336 |
predicted gene, 33336 |
12445 |
0.13 |
chr13_78200366_78200817 | 21.54 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
813 |
0.37 |
chr2_170902623_170902819 | 21.54 |
Gm14263 |
predicted gene 14263 |
52103 |
0.17 |
chr4_24429638_24429836 | 21.52 |
Gm27243 |
predicted gene 27243 |
1153 |
0.54 |
chr14_55029006_55029605 | 21.46 |
Ngdn |
neuroguidin, EIF4E binding protein |
7883 |
0.07 |
chr1_137373621_137374166 | 21.44 |
Gm23534 |
predicted gene, 23534 |
6646 |
0.26 |
chr13_84059669_84060031 | 21.41 |
Gm17750 |
predicted gene, 17750 |
4922 |
0.24 |
chr2_8478271_8478479 | 21.36 |
Gm13255 |
predicted gene 13255 |
155562 |
0.04 |
chr9_49606490_49606655 | 21.36 |
Ncam1 |
neural cell adhesion molecule 1 |
38023 |
0.19 |
chr7_97245754_97245926 | 21.34 |
Usp35 |
ubiquitin specific peptidase 35 |
69185 |
0.1 |
chr16_67610911_67611282 | 21.33 |
Cadm2 |
cell adhesion molecule 2 |
9397 |
0.25 |
chr14_60410314_60410651 | 21.29 |
Gm6066 |
predicted gene 6066 |
31497 |
0.16 |
chr16_41745029_41745397 | 21.29 |
Lsamp |
limbic system-associated membrane protein |
211794 |
0.02 |
chr5_113690280_113690481 | 21.26 |
1700069L16Rik |
RIKEN cDNA 1700069L16 gene |
14068 |
0.13 |
chr14_35244974_35245125 | 21.15 |
Gm49034 |
predicted gene, 49034 |
25611 |
0.26 |
chr3_6731494_6731645 | 21.07 |
Olfr289-ps1 |
olfactory receptor 289, pseudogene 1 |
20503 |
0.26 |
chr8_103072756_103072931 | 21.03 |
Gm45391 |
predicted gene 45391 |
72103 |
0.12 |
chr2_100259285_100259436 | 20.93 |
Gm13811 |
predicted gene 13811 |
76843 |
0.12 |
chr13_111651166_111651317 | 20.90 |
Mier3 |
MIER family member 3 |
29738 |
0.12 |
chr14_103763329_103763480 | 20.85 |
Slain1os |
SLAIN motif family, member 1, opposite strand |
63962 |
0.11 |
chr6_53696597_53696748 | 20.82 |
Gm44080 |
predicted gene, 44080 |
28902 |
0.2 |
chr1_165934961_165935308 | 20.80 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
123 |
0.95 |
chr2_4436351_4436936 | 20.78 |
Gm13175 |
predicted gene 13175 |
30027 |
0.16 |
chr18_81166272_81166423 | 20.77 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69719 |
0.09 |
chr18_45014470_45014883 | 20.74 |
Gm31706 |
predicted gene, 31706 |
30186 |
0.16 |
chr6_46612981_46613160 | 20.70 |
Gm18484 |
predicted gene, 18484 |
25212 |
0.22 |
chr10_75056229_75056655 | 20.53 |
Bcr |
BCR activator of RhoGEF and GTPase |
4150 |
0.19 |
chr17_61033847_61034240 | 20.34 |
Gm18070 |
predicted gene, 18070 |
17425 |
0.27 |
chr18_69608471_69608657 | 20.25 |
Tcf4 |
transcription factor 4 |
3880 |
0.32 |
chr2_26500316_26500756 | 20.19 |
Notch1 |
notch 1 |
3286 |
0.14 |
chr4_116857194_116857345 | 20.18 |
Gm12994 |
predicted gene 12994 |
4605 |
0.1 |
chr12_117988999_117989757 | 20.17 |
Dnah11 |
dynein, axonemal, heavy chain 11 |
70925 |
0.12 |
chr6_116385763_116386168 | 20.14 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
259 |
0.87 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.6 | 40.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
11.3 | 34.0 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
7.1 | 21.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
6.1 | 30.3 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
5.9 | 23.5 | GO:0001927 | exocyst assembly(GO:0001927) |
5.3 | 15.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
5.3 | 15.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
5.2 | 15.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.8 | 14.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
4.8 | 19.1 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
4.6 | 22.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
4.5 | 13.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
4.4 | 4.4 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
3.8 | 34.4 | GO:0050957 | equilibrioception(GO:0050957) |
3.8 | 30.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
3.6 | 14.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
3.6 | 32.1 | GO:0031223 | auditory behavior(GO:0031223) |
3.5 | 10.4 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
3.5 | 10.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.3 | 9.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
3.2 | 12.9 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
3.2 | 9.5 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
3.1 | 9.3 | GO:0007412 | axon target recognition(GO:0007412) |
3.1 | 15.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
3.0 | 12.0 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
2.9 | 14.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.8 | 8.3 | GO:0033058 | directional locomotion(GO:0033058) |
2.7 | 10.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
2.7 | 5.4 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.6 | 2.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
2.6 | 5.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
2.6 | 5.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.5 | 7.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.5 | 15.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
2.5 | 7.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.4 | 2.4 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
2.3 | 20.9 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
2.3 | 23.1 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
2.3 | 4.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.2 | 4.5 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
2.2 | 9.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.2 | 8.8 | GO:0061743 | motor learning(GO:0061743) |
2.2 | 4.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.2 | 19.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.2 | 17.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
2.1 | 23.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
2.1 | 4.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
2.1 | 4.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.1 | 8.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.1 | 8.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.1 | 12.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.1 | 10.4 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
2.1 | 10.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
2.0 | 6.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
2.0 | 2.0 | GO:1904395 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
2.0 | 5.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.9 | 5.8 | GO:0060005 | vestibular reflex(GO:0060005) |
1.9 | 3.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.9 | 7.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.9 | 5.7 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.9 | 11.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.9 | 1.9 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.8 | 3.6 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
1.8 | 10.9 | GO:0071625 | vocalization behavior(GO:0071625) |
1.8 | 5.4 | GO:0031296 | B cell costimulation(GO:0031296) |
1.8 | 5.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.8 | 12.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.8 | 8.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.8 | 7.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.7 | 5.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.7 | 5.1 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
1.7 | 5.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.7 | 10.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.7 | 8.4 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.7 | 6.7 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.6 | 4.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.6 | 4.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.6 | 8.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.6 | 8.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.6 | 6.4 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.6 | 4.8 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.6 | 3.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.6 | 33.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.6 | 6.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.5 | 3.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.5 | 4.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.5 | 6.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.5 | 6.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
1.5 | 6.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.5 | 8.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.5 | 4.4 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.4 | 4.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.4 | 1.4 | GO:0021564 | vagus nerve development(GO:0021564) |
1.4 | 1.4 | GO:0032196 | transposition(GO:0032196) |
1.4 | 4.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.4 | 4.2 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
1.4 | 5.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.4 | 4.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
1.4 | 4.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.4 | 6.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.4 | 2.8 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.4 | 1.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.4 | 9.5 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.3 | 17.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.3 | 4.0 | GO:0030070 | insulin processing(GO:0030070) |
1.3 | 1.3 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
1.3 | 2.7 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.3 | 22.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.3 | 4.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.3 | 2.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.3 | 1.3 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.3 | 5.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.3 | 5.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
1.3 | 3.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.3 | 6.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.3 | 3.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.3 | 3.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.3 | 42.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.3 | 2.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.3 | 15.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.3 | 2.5 | GO:0017085 | response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
1.2 | 3.7 | GO:0006562 | proline catabolic process(GO:0006562) |
1.2 | 6.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.2 | 3.7 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.2 | 4.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.2 | 4.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.2 | 14.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.2 | 4.8 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.2 | 5.9 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.2 | 1.2 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.2 | 8.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.2 | 1.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.2 | 3.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.2 | 3.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.2 | 15.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.2 | 4.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.1 | 3.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.1 | 3.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.1 | 2.3 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.1 | 7.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.1 | 6.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.1 | 3.3 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.1 | 26.8 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
1.1 | 3.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.1 | 1.1 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.1 | 3.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.1 | 4.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.0 | 12.5 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
1.0 | 3.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
1.0 | 1.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
1.0 | 5.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.0 | 5.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.0 | 3.0 | GO:0097503 | sialylation(GO:0097503) |
1.0 | 3.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.0 | 4.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.0 | 5.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.0 | 4.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.0 | 2.9 | GO:0015889 | cobalamin transport(GO:0015889) |
1.0 | 4.9 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
1.0 | 9.8 | GO:0008038 | neuron recognition(GO:0008038) |
1.0 | 1.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.9 | 2.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.9 | 0.9 | GO:0021586 | pons maturation(GO:0021586) |
0.9 | 5.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.9 | 0.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.9 | 23.2 | GO:0007616 | long-term memory(GO:0007616) |
0.9 | 13.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.9 | 1.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 44.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 1.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.9 | 26.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.9 | 1.8 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.9 | 6.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.9 | 21.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.9 | 2.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.9 | 4.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.9 | 1.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.9 | 9.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.9 | 5.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.9 | 3.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.9 | 3.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.9 | 3.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.9 | 3.4 | GO:0030432 | peristalsis(GO:0030432) |
0.9 | 4.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.8 | 4.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.8 | 5.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.8 | 2.5 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.8 | 1.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.8 | 3.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.8 | 0.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.8 | 3.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.8 | 1.6 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.8 | 3.2 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.8 | 4.7 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.8 | 7.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.8 | 5.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.8 | 3.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.8 | 0.8 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.8 | 0.8 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.8 | 3.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.8 | 7.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.7 | 1.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.7 | 1.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.7 | 5.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.7 | 1.5 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 1.5 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.7 | 8.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 1.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.7 | 0.7 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.7 | 5.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.7 | 2.9 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.7 | 6.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.7 | 2.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 0.7 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.7 | 19.4 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.7 | 5.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 2.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.7 | 2.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.7 | 1.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.7 | 6.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.7 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.7 | 16.8 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.7 | 2.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.7 | 3.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.7 | 2.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.7 | 2.1 | GO:0060437 | lung growth(GO:0060437) |
0.7 | 2.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.7 | 1.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.7 | 4.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.7 | 4.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.7 | 2.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.6 | 1.9 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.6 | 1.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.6 | 2.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 7.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.6 | 0.6 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.6 | 2.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.6 | 3.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.6 | 46.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 2.5 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.6 | 1.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.6 | 1.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.6 | 1.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.6 | 1.2 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.6 | 3.7 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.6 | 1.8 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.6 | 0.6 | GO:0060004 | reflex(GO:0060004) |
0.6 | 6.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.6 | 3.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.6 | 4.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.6 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.6 | 2.4 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.6 | 0.6 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.6 | 1.2 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.6 | 1.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.6 | 3.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 3.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.6 | 5.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.6 | 4.7 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.6 | 11.1 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.6 | 1.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.6 | 1.7 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.6 | 4.6 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.6 | 6.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.6 | 1.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.6 | 1.1 | GO:0061055 | myotome development(GO:0061055) |
0.6 | 1.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.6 | 1.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.6 | 2.2 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 1.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 3.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.5 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 2.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 1.6 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.5 | 1.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 3.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 5.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.5 | 3.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 5.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.5 | 0.5 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.5 | 7.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.5 | 1.0 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.5 | 1.6 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.5 | 7.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.5 | 1.0 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 3.1 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.5 | 1.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.5 | 3.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 1.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 1.5 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.5 | 0.5 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.5 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.5 | 0.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.5 | 1.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 1.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.5 | 1.9 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.5 | 2.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 0.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.5 | 1.0 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.5 | 0.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.5 | 0.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.5 | 0.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.5 | 3.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.5 | 2.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 2.3 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 1.8 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.5 | 1.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.5 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 3.6 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.5 | 1.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.4 | 0.9 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.4 | 4.9 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.4 | 1.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 1.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 1.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 1.3 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 1.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 4.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.4 | 0.4 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.4 | 5.6 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 2.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 3.0 | GO:0014047 | glutamate secretion(GO:0014047) |
0.4 | 1.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 0.9 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.4 | 1.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 2.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.4 | 2.1 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 2.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.4 | 1.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.4 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.4 | 10.2 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.4 | 3.7 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.4 | 1.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 1.2 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 4.0 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.4 | 0.4 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.4 | 0.4 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.4 | 1.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.4 | 0.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.4 | 1.6 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.4 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.4 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 1.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 1.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 1.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.4 | 3.0 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.4 | 0.7 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.4 | 4.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 2.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 2.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 3.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.4 | 1.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 1.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 0.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 0.4 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 1.8 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.4 | 0.4 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.4 | 1.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.4 | 1.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 1.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.4 | 1.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 8.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.3 | 21.1 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.3 | 1.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.3 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.7 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.3 | 1.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.3 | 1.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 7.1 | GO:0007588 | excretion(GO:0007588) |
0.3 | 0.3 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 0.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.3 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 1.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.3 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 0.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 | 0.3 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.3 | 0.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.3 | 3.2 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.3 | 1.0 | GO:0007567 | parturition(GO:0007567) |
0.3 | 1.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 2.8 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.3 | 0.9 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 0.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.3 | 0.3 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.3 | 0.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 1.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 0.9 | GO:0014819 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of skeletal muscle contraction(GO:0014819) |
0.3 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 1.8 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 1.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 0.3 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.3 | 2.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 1.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.3 | 0.9 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.3 | 0.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.9 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 2.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 1.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 0.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 1.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 4.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 0.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.8 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.3 | 0.3 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.3 | 0.8 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 3.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 0.3 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.3 | 2.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 0.8 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 1.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 0.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 1.3 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 1.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 5.7 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 1.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 1.8 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.3 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 0.8 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.3 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 7.3 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.3 | 1.8 | GO:0030325 | adrenal gland development(GO:0030325) |
0.2 | 1.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.5 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.2 | 1.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 1.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 0.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.2 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.2 | 0.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.7 | GO:0090102 | cochlea development(GO:0090102) |
0.2 | 0.9 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 2.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.9 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 0.7 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 1.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 1.7 | GO:0036035 | osteoclast development(GO:0036035) |
0.2 | 1.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.8 | GO:0043476 | pigment accumulation(GO:0043476) |
0.2 | 0.8 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.4 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.2 | 0.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.2 | 1.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 1.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.6 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 2.4 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.8 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.8 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.2 | 1.8 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 1.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.8 | GO:0007320 | insemination(GO:0007320) |
0.2 | 2.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 1.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 1.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.2 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 1.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 0.9 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.9 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 0.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 0.4 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.2 | GO:0046959 | habituation(GO:0046959) |
0.2 | 0.6 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.2 | 0.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 2.7 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.2 | 2.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 0.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 3.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.5 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 1.6 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.2 | 0.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 1.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 1.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.5 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 1.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.3 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 2.0 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.2 | 3.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.6 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 1.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.5 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 4.8 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 1.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 2.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.5 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 1.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 1.1 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 1.9 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.2 | 0.5 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 2.0 | GO:0006833 | water transport(GO:0006833) |
0.2 | 0.2 | GO:0060066 | oviduct development(GO:0060066) mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.2 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 2.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.1 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.1 | 0.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.6 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.7 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.7 | GO:0086009 | membrane repolarization(GO:0086009) |
0.1 | 0.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.3 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.1 | 1.2 | GO:0098868 | bone growth(GO:0098868) |
0.1 | 0.3 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 1.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 1.3 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.1 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 1.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.4 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.9 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.4 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.1 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.1 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.4 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 1.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 1.3 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.1 | 2.0 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 1.1 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 1.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 2.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.5 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.8 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 2.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.6 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.9 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.4 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.7 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.8 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.4 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.4 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.1 | 0.3 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.1 | 0.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.1 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.2 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) |
0.1 | 0.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.9 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.3 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0061724 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.2 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 1.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 1.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 0.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.6 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.1 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.8 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 2.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.3 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.1 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.3 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 1.2 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.1 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.0 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.0 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.0 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.2 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.0 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 0.1 | GO:0072017 | distal tubule development(GO:0072017) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.0 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.0 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.0 | GO:0072677 | eosinophil migration(GO:0072677) |
0.0 | 0.1 | GO:1901380 | negative regulation of potassium ion transmembrane transport(GO:1901380) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.0 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.0 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.0 | 0.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.1 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.7 | GO:0072534 | perineuronal net(GO:0072534) |
3.9 | 3.9 | GO:0097513 | myosin II filament(GO:0097513) |
3.8 | 18.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
3.0 | 36.0 | GO:0043194 | axon initial segment(GO:0043194) |
2.9 | 8.8 | GO:0005608 | laminin-3 complex(GO:0005608) |
2.9 | 54.6 | GO:0030673 | axolemma(GO:0030673) |
2.8 | 5.6 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.4 | 9.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
2.2 | 6.5 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.9 | 7.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.9 | 5.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.8 | 1.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.8 | 5.3 | GO:0043511 | inhibin complex(GO:0043511) |
1.7 | 5.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.7 | 30.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.6 | 9.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.6 | 43.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.6 | 4.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.5 | 4.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.5 | 10.2 | GO:0032584 | growth cone membrane(GO:0032584) |
1.4 | 4.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.4 | 4.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.4 | 14.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.4 | 11.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 5.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.3 | 12.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.3 | 1.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.2 | 17.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.2 | 13.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
1.1 | 4.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.1 | 45.7 | GO:0043198 | dendritic shaft(GO:0043198) |
1.0 | 3.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 4.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.0 | 46.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.0 | 3.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 3.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
1.0 | 7.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.9 | 9.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.9 | 9.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.8 | 2.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.8 | 11.4 | GO:0000145 | exocyst(GO:0000145) |
0.8 | 4.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.8 | 26.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.8 | 3.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.8 | 10.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.8 | 70.3 | GO:0043204 | perikaryon(GO:0043204) |
0.8 | 6.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.8 | 4.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.8 | 16.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.7 | 5.9 | GO:0000243 | commitment complex(GO:0000243) |
0.7 | 2.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.7 | 1.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.6 | 1.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 1.9 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 3.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 2.5 | GO:0097433 | dense body(GO:0097433) |
0.6 | 4.4 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 5.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 0.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.6 | 1.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.6 | 5.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.6 | 81.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 5.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.6 | 1.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.6 | 2.9 | GO:0071547 | piP-body(GO:0071547) |
0.6 | 7.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 1.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 2.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.5 | 2.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 3.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.5 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 3.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 1.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.5 | 2.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.5 | 8.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.5 | 4.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 3.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 2.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 21.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 2.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.5 | 0.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.5 | 1.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 2.6 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 1.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 1.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 1.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 3.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 2.9 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 8.2 | GO:0032420 | stereocilium(GO:0032420) |
0.4 | 1.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 1.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 3.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 1.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 3.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 4.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 20.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 8.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 5.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 3.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 15.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 1.9 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 2.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 12.7 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 3.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 42.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 0.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 0.6 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 3.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 2.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 1.4 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 2.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 5.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 1.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.7 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 10.3 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 1.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 1.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 2.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 7.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 1.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 9.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 2.9 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 1.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 1.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.2 | 0.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 9.0 | GO:0098793 | presynapse(GO:0098793) |
0.2 | 4.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 2.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 0.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 2.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 1.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.8 | GO:0031082 | BLOC complex(GO:0031082) |
0.2 | 1.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 1.7 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 1.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 2.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.8 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 4.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 1.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.1 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 1.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.5 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 1.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.2 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 4.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 1.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 1.8 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.5 | 25.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
7.9 | 23.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
6.1 | 18.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
5.8 | 29.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.3 | 21.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
4.1 | 12.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
4.1 | 12.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
3.6 | 10.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
3.3 | 9.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.1 | 15.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
3.0 | 36.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
2.8 | 25.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
2.7 | 10.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.6 | 46.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
2.6 | 10.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.4 | 21.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.4 | 7.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.2 | 8.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
2.1 | 27.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
2.1 | 8.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
2.0 | 10.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.0 | 5.9 | GO:0097016 | L27 domain binding(GO:0097016) |
1.8 | 44.1 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.7 | 7.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.7 | 13.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.7 | 8.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.7 | 5.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.7 | 13.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.6 | 51.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.5 | 7.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.5 | 8.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.5 | 2.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.4 | 4.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.4 | 4.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.4 | 4.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.4 | 4.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.4 | 8.3 | GO:0002054 | nucleobase binding(GO:0002054) |
1.4 | 8.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.4 | 9.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.3 | 5.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.3 | 3.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.3 | 3.9 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.3 | 6.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.3 | 3.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.3 | 2.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.2 | 3.7 | GO:0042731 | PH domain binding(GO:0042731) |
1.2 | 4.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.2 | 2.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 8.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.2 | 2.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.2 | 3.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.1 | 3.4 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.1 | 2.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 12.0 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
1.1 | 4.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.0 | 23.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.0 | 3.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.0 | 20.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.0 | 4.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.0 | 4.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.0 | 2.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.9 | 4.7 | GO:0070728 | leucine binding(GO:0070728) |
0.9 | 4.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.9 | 9.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.9 | 4.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.9 | 5.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.9 | 6.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.9 | 7.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.9 | 7.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.8 | 2.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.8 | 2.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.8 | 4.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.8 | 5.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.8 | 19.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.8 | 4.9 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.8 | 2.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 4.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.8 | 2.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.8 | 8.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.8 | 21.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.8 | 5.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.8 | 3.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.8 | 5.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.8 | 0.8 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 3.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.8 | 3.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.8 | 6.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.7 | 7.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.7 | 1.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.7 | 2.2 | GO:0043918 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.7 | 2.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 22.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.7 | 2.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.7 | 9.2 | GO:0031005 | filamin binding(GO:0031005) |
0.7 | 7.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.7 | 7.5 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 4.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 2.0 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.7 | 4.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.6 | 6.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.6 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 1.9 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 1.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 3.8 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 11.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.6 | 2.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.6 | 4.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.6 | 3.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.6 | 10.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.6 | 1.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.6 | 2.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.6 | 2.8 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.6 | 1.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.5 | 2.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 2.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.5 | 17.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 2.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 2.1 | GO:0002046 | opsin binding(GO:0002046) |
0.5 | 3.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 4.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.5 | 1.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.5 | 7.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.5 | 1.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 3.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.5 | 3.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.5 | 2.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 1.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.5 | 2.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 4.9 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.5 | 5.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.5 | 1.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 10.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 2.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 3.8 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.5 | 12.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 1.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 1.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.4 | 1.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 8.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 1.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 16.8 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.4 | 4.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 8.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 5.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 6.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 6.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 14.1 | GO:0017022 | myosin binding(GO:0017022) |
0.4 | 1.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 0.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.4 | 6.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 7.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 2.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 2.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.4 | 7.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 0.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.4 | 1.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 1.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 4.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 7.5 | GO:0043813 | phosphohistidine phosphatase activity(GO:0008969) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) NADP phosphatase activity(GO:0019178) inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) 5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity(GO:0043726) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052867) IDP phosphatase activity(GO:1990003) |
0.3 | 0.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.3 | 2.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 1.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 1.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 22.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.3 | 2.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 2.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 2.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 3.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 3.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.0 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.3 | 6.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 4.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 1.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 1.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 1.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 6.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 0.9 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 2.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 1.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 4.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 0.9 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 3.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 7.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 0.3 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 4.6 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 2.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 0.5 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 1.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 1.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 0.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 0.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.5 | GO:0015265 | urea transmembrane transporter activity(GO:0015204) urea channel activity(GO:0015265) |
0.3 | 0.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 12.0 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 0.7 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 2.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 2.4 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 2.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 4.5 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.4 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 0.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 5.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 1.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.8 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 6.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 4.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 6.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 0.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 5.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 11.6 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 2.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 1.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 4.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 3.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 1.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 2.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 4.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 0.8 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 2.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 1.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 5.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 0.5 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.2 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 1.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 1.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 2.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 2.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 1.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.5 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.2 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 2.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 1.3 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.3 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 1.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 1.7 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.5 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 1.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 2.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 2.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.6 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 1.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 3.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 1.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 2.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 2.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 2.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 4.8 | GO:0015297 | antiporter activity(GO:0015297) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 4.6 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.3 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 1.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 3.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 4.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.1 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.1 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 1.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 3.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.9 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 3.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.3 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 12.5 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.0 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.0 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.0 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.5 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.1 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 3.6 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.1 | 16.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.1 | 16.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 1.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.8 | 1.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 1.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.6 | 0.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 31.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.6 | 6.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 4.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 5.0 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 6.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 0.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 11.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 4.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 12.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 1.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.4 | 7.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 4.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 3.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 2.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 2.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 5.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 3.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 7.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 9.2 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 7.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 6.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 2.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 4.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 1.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 4.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 4.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 2.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 6.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 43.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.0 | 27.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.9 | 20.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.8 | 29.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.8 | 40.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.5 | 31.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.4 | 30.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.3 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.3 | 31.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.2 | 14.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
1.2 | 47.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.9 | 31.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.9 | 10.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.8 | 10.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.8 | 3.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.8 | 10.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.7 | 7.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.7 | 2.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.7 | 2.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.7 | 3.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.7 | 9.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 10.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.7 | 7.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 4.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.6 | 5.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.6 | 5.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.6 | 18.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.6 | 15.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 4.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 2.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 5.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.5 | 5.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 4.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 5.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 8.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 4.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 3.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 3.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 3.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 9.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 5.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 4.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 1.3 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.3 | 2.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 2.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 2.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 4.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 2.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 3.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 2.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 6.7 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.2 | 0.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 5.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 1.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 7.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 1.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 4.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 1.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 7.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 0.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 2.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 2.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 2.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 2.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 15.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 5.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.7 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 2.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |